Mulmit

Innoviva, Inc.Innoviva, Inc.

INVA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31411,328,000163,745,0003.3
2024-12-31358,711,000166,867,0000.36
2023-12-31310,463,000113,885,0002.2
2022-12-31331,339,0002.37
2021-12-31391,866,000375,103,0002.87

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-20Zhen MarianneChief Accounting Officer1,127
2026-08-20Basso StephenChief Financial Officer558
2026-08-20Raifeld PavelChief Executive Officer1,130
2026-05-20Basso StephenChief Financial Officer559
2026-05-20Raifeld PavelChief Executive Officer1,130
2026-05-20Zhen MarianneChief Accounting Officer1,127
2026-05-18Linden Josephine5,733
2026-05-18Linden Josephine9,461
2026-05-18Linden Josephine9,166
2026-05-15Basso StephenChief Financial Officer1,123
2026-05-15Raifeld PavelChief Executive Officer1,123
2026-05-04DiPaolo Mark9,786

8-K events

FiledItems
2026-08-05Results of operations · Financial statements and exhibits
2026-05-18Officer or director change · Financial statements and exhibits
2026-05-06Results of operations · Financial statements and exhibits
2026-05-04Submission of matters to a vote
2026-02-25Results of operations · Financial statements and exhibits
2025-11-05Results of operations · Financial statements and exhibits
2025-08-06Results of operations · Financial statements and exhibits
2025-05-21Submission of matters to a vote
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.